Mira Pharmaceuticals (MIRA) Profit After Tax (2022 - 2025)

Mira Pharmaceuticals has disclosed Profit After Tax across 4 years of filings, most recently posting -$5.9 million for Q4 2025.

• Profit After Tax for Q4 2025 came in at -$5.9 million, down 147.57% year-over-year; the trailing twelve-month figure through Dec 2025 was -$10.4 million (down 32.44% YoY), and the FY2025 annual result was -$10.4 million, down 32.44% from the prior year.
• Profit After Tax came in at -$5.9 million for Q4 2025 at Mira Pharmaceuticals, down from -$1.1 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$1.1 million in Q3 2025 to a low of -$5.9 million in Q4 2025.
• The 4-year median for Profit After Tax is -$1.8 million (2025), against an average of -$2.4 million.
• Across the five-year window, Profit After Tax tumbled 328.86% in 2023 and soared 58.54% in 2024, its largest moves.
• Mira Pharmaceuticals' Profit After Tax stood at -$1.3 million in 2022, then tumbled by 328.86% to -$5.8 million in 2023, then jumped by 58.54% to -$2.4 million in 2024, then tumbled by 147.57% to -$5.9 million in 2025.
• The last three Profit After Tax figures came in at -$5.9 million (Q4 2025), -$1.1 million (Q3 2025), and -$1.5 million (Q2 2025), per Business Quant data.